NCT01878708 2017-03-06A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaDana-Farber Cancer InstitutePhase EARLY_PHASE1 Terminated2 enrolled